237 related articles for article (PubMed ID: 35654170)
1. Trends in advanced oral drug delivery system for curcumin: A systematic review.
Pan-On S; Dilokthornsakul P; Tiyaboonchai W
J Control Release; 2022 Aug; 348():335-345. PubMed ID: 35654170
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
Ma Z; Wang N; He H; Tang X
J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
Mohanty C; Das M; Sahoo SK
Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
[TBL] [Abstract][Full Text] [Related]
4. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Oral Delivery of Curcumin via Vitamin E TPGS Modified Nanodiamonds: a Comparative Study on the Efficacy of Non-covalent and Covalent Conjugated Strategies.
Liu D; Qiao S; Cheng B; Li D; Chen J; Wu Q; Pan H; Pan W
AAPS PharmSciTech; 2020 Jul; 21(5):187. PubMed ID: 32642862
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in nanogold as a promising nanocarrier for curcumin delivery.
Mahmoudi A; Kesharwani P; Majeed M; Teng Y; Sahebkar A
Colloids Surf B Biointerfaces; 2022 Jul; 215():112481. PubMed ID: 35453063
[TBL] [Abstract][Full Text] [Related]
8. Advances in oral delivery of anti-cancer prodrugs.
Jain AK; Jain S
Expert Opin Drug Deliv; 2016 Dec; 13(12):1759-1775. PubMed ID: 27292717
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review.
Morshedi K; Borran S; Ebrahimi MS; Masoud Khooy MJ; Seyedi ZS; Amiri A; Abbasi-Kolli M; Fallah M; Khan H; Sahebkar A; Mirzaei H
Phytother Res; 2021 Sep; 35(9):4834-4897. PubMed ID: 34173992
[TBL] [Abstract][Full Text] [Related]
11. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
Kolter M; Wittmann M; Köll-Weber M; Süss R
Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
[TBL] [Abstract][Full Text] [Related]
12. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.
Parikh A; Kathawala K; Song Y; Zhou XF; Garg S
Drug Deliv Transl Res; 2018 Oct; 8(5):1389-1405. PubMed ID: 29845380
[TBL] [Abstract][Full Text] [Related]
14. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.
Hou Y; Wang H; Zhang F; Sun F; Xin M; Li M; Li J; Wu X
Int J Nanomedicine; 2019; 14():557-571. PubMed ID: 30666114
[TBL] [Abstract][Full Text] [Related]
15. Preparation, optimization and preliminary pharmacokinetic study of curcumin encapsulated turmeric oil microemulsion in zebra fish.
More SK; Pawar AP
Eur J Pharm Sci; 2020 Dec; 155():105539. PubMed ID: 32898637
[TBL] [Abstract][Full Text] [Related]
16. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.
Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z
Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis.
Fong SY; Brandl M; Bauer-Brandl A
Eur J Pharm Sci; 2015 Dec; 80():89-110. PubMed ID: 26296863
[TBL] [Abstract][Full Text] [Related]
19. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
Ipar VS; Dsouza A; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]